![]()
|
|
||||||||
J. Biol. Chem., Vol. 263, Issue 22, 10608-10612, Aug, 1988
N Feuerstein, PK Chan and JJ Mond
Department of Medicine, Uniformed Services University of the Health Sciences, Bethesda, Maryland 20814.
We have previously described and characterized a nuclear protein at 40 kDa/pI 5 termed "numatrin" which is tightly bound to the nuclear matrix. We demonstrated that a rapid increase in the synthesis of numatrin at early G1 phase is closely correlated with receptor-mediated induction of cellular proliferation by various mitogens and that elevated amounts of numatrin are found in tumor cells, suggesting that numatrin may have an important role in regulation of cellular growth in normal and malignant cells. Further experiments were undertaken to compare the biochemical characteristics of numatrin to those of other known proteins that are associated with cellular mitogenesis. Comparison of the electrophoretic mobility of numatrin with the proliferation cell nuclear antigen/cyclin showed that these proteins are not identical. However, numatrin had an identical electrophoretic migration on two-dimensional gel electrophoresis to that of a previously described nucleolar protein B23. The tryptic digest peptide map of 125I-labeled B23 was identical to that of numatrin on two- dimensional thin layer electrophoresis/chromatography. Labeling of cells with 32P further showed that numatrin is a major phosphoprotein as previously reported for protein B23. Using the protocol for purification of B23, we purified numatrin from nucleoli of HL-60 cells and produced two polyclonal antibodies (303 and 339) to this protein. We further show that numatrin is recognized by anti-B23 monoclonal antibody as well as by polyclonal antibodies 303 and 339 in enzyme- linked immunosorbent assay. Conversely, these anti-numatrin polyclonal antibodies cross-react with protein B23 as shown in immunoblot analysis. These results, taken collectively, prove that numatrin is identical to the nucleolar protein B23 and thus suggest that protein B23 and events which occur at the nucleolus might have an important role in early transduction of mitogenic signals at the G1 phase of the cell cycle.
This article has been cited by other articles:
![]() |
J. Li, D. P. Sejas, S. Burma, D. J. Chen, and Q. Pang Nucleophosmin suppresses oncogene-induced apoptosis and senescence and enhances oncogenic cooperation in cells with genomic instability Carcinogenesis, June 1, 2007; 28(6): 1163 - 1170. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. K. Sandsmark, H. Zhang, B. Hegedus, C. L. Pelletier, J. D. Weber, and D. H. Gutmann Nucleophosmin Mediates Mammalian Target of Rapamycin-Dependent Actin Cytoskeleton Dynamics and Proliferation in Neurofibromin-Deficient Astrocytes Cancer Res., May 15, 2007; 67(10): 4790 - 4799. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Falini, I. Nicoletti, N. Bolli, M. P. Martelli, A. Liso, P. Gorello, F. Mandelli, C. Mecucci, and M. F. Martelli Translocations and mutations involving the nucleophosmin (NPM1) gene in lymphomas and leukemias Haematologica, April 1, 2007; 92(4): 519 - 532. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. L. Pelletier, L. B. Maggi Jr., S. N. Brady, D. K. Scheidenhelm, D. H. Gutmann, and J. D. Weber TSC1 Sets the Rate of Ribosome Export and Protein Synthesis through Nucleophosmin Translation Cancer Res., February 15, 2007; 67(4): 1609 - 1617. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Falini, I. Nicoletti, M. F. Martelli, and C. Mecucci Acute myeloid leukemia carrying cytoplasmic/mutated nucleophosmin (NPMc+ AML): biologic and clinical features Blood, February 1, 2007; 109(3): 874 - 885. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Eirin-Lopez, L. J. Frehlick, and J. Ausio Long-Term Evolution and Functional Diversification in the Members of the Nucleophosmin/Nucleoplasmin Family of Nuclear Chaperones Genetics, August 1, 2006; 173(4): 1835 - 1850. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Li, D. P. Sejas, R. Rani, T. Koretsky, G. C. Bagby, and Q. Pang Nucleophosmin Regulates Cell Cycle Progression and Stress Response in Hematopoietic Stem/Progenitor Cells J. Biol. Chem., June 16, 2006; 281(24): 16536 - 16545. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. S. Meder, M. Boeglin, G. de Murcia, and V. Schreiber PARP-1 and PARP-2 interact with nucleophosmin/B23 and accumulate in transcriptionally active nucleoli J. Cell Sci., January 1, 2005; 118(1): 211 - 222. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. N. Brady, Y. Yu, L. B. Maggi Jr., and J. D. Weber ARF Impedes NPM/B23 Shuttling in an Mdm2-Sensitive Tumor Suppressor Pathway Mol. Cell. Biol., November 1, 2004; 24(21): 9327 - 9338. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Li, X. Zhang, D. P. Sejas, G. C. Bagby, and Q. Pang Hypoxia-induced Nucleophosmin Protects Cell Death through Inhibition of p53 J. Biol. Chem., October 1, 2004; 279(40): 41275 - 41279. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Pang, T. A. Christianson, T. Koretsky, H. Carlson, L. David, W. Keeble, G. R. Faulkner, A. Speckhart, and G. C. Bagby Nucleophosmin Interacts with and Inhibits the Catalytic Function of Eukaryotic Initiation Factor 2 Kinase PKR J. Biol. Chem., October 24, 2003; 278(43): 41709 - 41717. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. H. Wu and B. Y. M. Yung UV Stimulation of Nucleophosmin/B23 Expression Is an Immediate-early Gene Response Induced by Damaged DNA J. Biol. Chem., December 6, 2002; 277(50): 48234 - 48240. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Kutok and J. C. Aster Molecular Biology of Anaplastic Lymphoma Kinase-Positive Anaplastic Large-Cell Lymphoma J. Clin. Oncol., September 1, 2002; 20(17): 3691 - 3702. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. H. Wu, J. H. Chang, and B. Y.M. Yung Resistance to UV-induced cell-killing in nucleophosmin/B23 over-expressed NIH 3T3 fibroblasts: enhancement of DNA repair and up-regulation of PCNA in association with nucleophosmin/B23 over-expression Carcinogenesis, January 1, 2002; 23(1): 93 - 100. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Feuerstein, F. Chen, M. Madaio, M. Maldonado, and R. A. Eisenberg Induction of Autoimmunity in a Transgenic Model of B Cell Receptor Peripheral Tolerance: Changes in Coreceptors and B Cell Receptor-Induced Tyrosine-Phosphoproteins J. Immunol., November 15, 1999; 163(10): 5287 - 5297. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Melnick and J. D. Licht Deconstructing a Disease: RAR{alpha}, Its Fusion Partners, and Their Roles in the Pathogenesis of Acute Promyelocytic Leukemia Blood, May 15, 1999; 93(10): 3167 - 3215. [Full Text] [PDF] |
||||
![]() |
J. L. Cordell, K. A.F. Pulford, B. Bigerna, G. Roncador, A. Banham, E. Colombo, P.-G. Pelicci, D. Y. Mason, and B. Falini Detection of Normal and Chimeric Nucleophosmin in Human Cells Blood, January 15, 1999; 93(2): 632 - 642. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Firestein and N. Feuerstein Association of Activating Transcription Factor 2 (ATF2) with the Ubiquitin-conjugating Enzyme hUBC9. IMPLICATION OF THE UBIQUITIN/PROTEASOME PATHWAY IN REGULATION OF ATF2 IN T CELLS J. Biol. Chem., March 6, 1998; 273(10): 5892 - 5902. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Raziuddin, D. Court, F. H. Sarkar, Y.-L. Liu, H.-f. Kung, and R. Raziuddin A c-erbB-2 Promoter-specific Nuclear Matrix Protein from Human Breast Tumor Tissues Mediates NF-kappa B DNA Binding Activity J. Biol. Chem., June 20, 1997; 272(25): 15715 - 15720. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. D. Patterson, J. S. Grossman, P. D'Andrea, and G. I. Latter Reduced Numatrin/B23/Nucleophosmin Labeling in Apoptotic Jurkat T-lymphoblasts J. Biol. Chem., April 21, 1995; 270(16): 9429 - 9436. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |